AdaptHealth Corp. Quarterly Costs and Expenses in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
AdaptHealth Corp. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q3 2024.
  • AdaptHealth Corp. Costs and Expenses for the quarter ending September 30, 2024 was $742M, a 41.3% decline year-over-year.
  • AdaptHealth Corp. Costs and Expenses for the twelve months ending September 30, 2024 was $3.31B, a 4.65% decline year-over-year.
  • AdaptHealth Corp. annual Costs and Expenses for 2023 was $3.8B, a 36.6% increase from 2022.
  • AdaptHealth Corp. annual Costs and Expenses for 2022 was $2.78B, a 24.1% increase from 2021.
  • AdaptHealth Corp. annual Costs and Expenses for 2021 was $2.24B, a 124% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.31B $742M -$523M -41.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $3.84B $754M +$14.9M +2.02% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $3.82B $742M +$23.5M +3.27% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.8B $1.08B +$322M +42.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $3.48B $1.27B +$562M +79.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $2.91B $739M +$70.6M +10.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $2.84B $718M +$63.8M +9.75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $2.78B $754M +$110M +17.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $2.67B $704M +$126M +21.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.54B $668M +$117M +21.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $2.43B $655M +$188M +40.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.24B $644M +$315M +96% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $1.92B $578M +$306M +113% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.62B $552M +$335M +155% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.28B $467M +$283M +155% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $999M $328M +$179M +120% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $820M $271M +$143M +112% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $677M $217M +$107M +98.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $569M $183M +$69.1M +60.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $500M $149M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $128M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $109M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $114M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.